Cholestin (Monascus purpureus rice) inhibits homocysteine-induced reactive oxygen species generation, nuclear factor-κB activation, and vascular cell adhesion molecule-1 expression in human aortic endothelial cells

Journal of Biomedical Science

Volumn 15, Issue 2, 2008, Pages 183-196

  Lin, Chih Pei ^a,b   Chen, Yung Hsiang ^a,c   Chen, Jaw Wen ^a,b   Leu, Hsin Bang ^a,b   Liu, Tsan Zon ^d   Liu, Po Len ^e   Huang, Song Lih ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cell adhesion molecule; Cholestin (Monascus purpureus rice red yeast rice); Homocysteine; Nuclear factor B; Oxidative stress; Statins

Indexed keywords

CHOLESTIN; HOMOCYSTEINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PRAVASTATIN; REACTIVE OXYGEN METABOLITE; SIMVASTATIN; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; ENDOTHELIUM CELL; IMMUNOBLOTTING; IN VIVO STUDY; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS;

MONASCUS PURPUREUS;

EID: 39849100592     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/s11373-007-9212-0     Document Type: Article

References (59)

1. 1. D. Heber I. Yip J.M. Ashley D.A. Elashoff R.M. Elashoff V.L. Go 1999 Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement Am. J. Clin. Nutr. 69 231 236 9989685 1:CAS:528:DyaK1MXovVKitQ%3D%3D Heber D., Yip I., Ashley J.M., Elashoff D.A., Elashoff R.M., Go V.L. (1999) Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement. Am. J. Clin. Nutr. 69: 231–236
2. 2. R.Y. Man E.G. Lynn F. Cheung P.S. Tsang O. Karmin 2002 Cholestin inhibits cholesterol synthesis and secretion in hepatic cells (HepG2) Mol. Cell. Biochem. 233 153 158 12083370 10.1023/A:1017487815091 1:CAS:528:DC%2BD38XlsVCmsrg%3D Man R.Y., Lynn E.G., Cheung F., Tsang P.S., Karmin O. (2002) Cholestin inhibits cholesterol synthesis and secretion in hepatic cells (HepG2). Mol. Cell. Biochem. 233: 153–158
3. 3. W. Wei C. Li Y. Wang H. Su J. Zhu D. Kritchevsky 2003 Hypolipidemic and anti-atherogenic effects of long-term Cholestin (Monascus purpureus-fermented rice, red yeast rice) in cholesterol fed rabbits J. Nutr. Biochem. 14 314 318 12873712 10.1016/S0955-2863(03)00051-2 1:CAS:528:DC%2BD3sXlsVahuro%3D Wei W., Li C., Wang Y., Su H., Zhu J., Kritchevsky D. (2003) Hypolipidemic and anti-atherogenic effects of long-term Cholestin (Monascus purpureus-fermented rice, red yeast rice) in cholesterol fed rabbits. J. Nutr. Biochem. 14: 314–318
4. 4. J. Ma Y. Li Q. Ye J. Li Y. Hua D. Ju D. Zhang R. Cooper M. Chang 2000 Constituents of red yeast rice, a traditional Chinese food and medicine J. Agric. Food Chem. 48 5220 5225 11087463 10.1021/jf000338c 1:CAS:528:DC%2BD3cXnt1SlsLo%3D Ma J., Li Y., Ye Q., Li J., Hua Y., Ju D., Zhang D., Cooper R., Chang M. (2000) Constituents of red yeast rice, a traditional Chinese food and medicine. J. Agric. Food Chem. 48: 5220–5225
5. 5. W. Zhang Z. Duan S. X 1998 Active components of Xuezhikang Chinese J. New Drugs 7 213 214 Zhang W., Duan Z., X.S. (1998) Active components of Xuezhikang. Chinese J. New Drugs 7: 213–214
6. 6. M.B. Katan P.L. Zock R.P. Mensink 1994 Effects of fats and fatty acids on blood lipids in humans: an overview Am. J. Clin. Nutr. 60 1017S 1022S 7977143 1:CAS:528:DyaK2MXivVGqtbY%3D Katan M.B., Zock P.L., Mensink R.P. (1994) Effects of fats and fatty acids on blood lipids in humans: an overview. Am. J. Clin. Nutr. 60: 1017S-1022S
7. 7. G.J. Hankey J.W. Eikelboom 1999 Homocysteine and vascular disease Lancet 354 407 413 10437885 10.1016/S0140-6736(98)11058-9 1:CAS:528:DyaK1MXlt1ajur0%3D Hankey G.J., Eikelboom J.W. (1999) Homocysteine and vascular disease. Lancet 354: 407–413
8. 8. O. Nygard J.E. Nordrehaug H. Refsum P.M. Ueland M. Farstad S.E. Vollset 1997 Plasma homocysteine levels and mortality in patients with coronary artery disease N. Engl. J. Med. 337 230 236 9227928 10.1056/NEJM199707243370403 1:STN:280:ByiA2MjisVA%3D Nygard O., Nordrehaug J.E., Refsum H., Ueland P.M., Farstad M., Vollset S.E. (1997) Plasma homocysteine levels and mortality in patients with coronary artery disease. N. Engl. J. Med. 337: 230–236
9. 9. K.S. Woo P. Chook Y.I. Lolin A.S. Cheung L.T. Chan Y.Y. Sun J.E. Sanderson C. Metreweli D.S. Celermajer 1997 Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans Circulation 96 2542 2544 9355891 1:CAS:528:DyaK2sXnt1Kks7Y%3D Woo K.S., Chook P., Lolin Y.I., Cheung A.S., Chan L.T., Sun Y.Y., Sanderson J.E., Metreweli C., Celermajer D.S. (1997) Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans. Circulation 96: 2542–2544
10. 10. R.T. Wall J.M. Harlan L.A. Harker G.E. Striker 1980 Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury Thromb. Res. 18 113 121 7404495 10.1016/0049-3848(80)90175-9 1:CAS:528:DyaL3cXksVeju78%3D Wall R.T., Harlan J.M., Harker L.A., Striker G.E. (1980) Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. Thromb. Res. 18: 113–121
11. 11. G.M. Rodgers W.H. Kane 1986 Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator J. Clin. Invest. 77 1909 1916 3519683 1:CAS:528:DyaL28XksFyqu78%3D Rodgers G.M., Kane W.H. (1986) Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. J. Clin. Invest. 77: 1909–1916
12. 12. J.S. Stamler J.A. Osborne O. Jaraki L.E. Rabbani M. Mullins D. Singel J. Loscalzo 1993 Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen J. Clin. Invest. 91 308 318 8380812 1:CAS:528:DyaK3sXhsVCrsbw%3D 10.1172/JCI116187 Stamler J.S., Osborne J.A., Jaraki O., Rabbani L.E., Mullins M., Singel D., Loscalzo J. (1993) Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J. Clin. Invest. 91: 308–318
13. 13. D. Pruefer R. Scalia A.M. Lefer 1999 Homocysteine provokes leukocyte-endothelium interaction by downregulation of nitric oxide Gen. Pharmacol. 33 487 498 10647774 10.1016/S0306-3623(99)00045-2 1:CAS:528:DC%2BD3cXltVKisg%3D%3D Pruefer D., Scalia R., Lefer A.M. (1999) Homocysteine provokes leukocyte-endothelium interaction by downregulation of nitric oxide. Gen. Pharmacol. 33: 487–498
14. 14. G.R. Upchurch Jr. G.N. Welch A.J. Fabian J.E. Freedman J.L. Johnson J.F. Keaney Jr. J. Loscalzo 1997 Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase J. Biol. Chem. 272 17012 17017 9202015 10.1074/jbc.272.27.17012 1:CAS:528:DyaK2sXksVeltbs%3D Upchurch G.R. Jr., Welch G.N., Fabian A.J., Freedman J.E., Johnson J.L., Keaney J.F. Jr., Loscalzo J. (1997) Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J. Biol. Chem. 272: 17012–17017
15. 15. Z. Ungvari A. Csiszar J.G. Edwards P.M. Kaminski M.S. Wolin G. Kaley A. Koller 2003 Increased superoxide production in coronary arteries in hyperhomocysteinemia: role of tumor necrosis factor-alpha, NAD(P)H oxidase, and inducible nitric oxide synthase Arterioscler. Thromb. Vasc. Biol. 23 418 424 12615666 10.1161/01.ATV.0000061735.85377.40 1:CAS:528:DC%2BD3sXhslWhsbY%3D Ungvari Z., Csiszar A., Edwards J.G., Kaminski P.M., Wolin M.S., Kaley G., Koller A. (2003) Increased superoxide production in coronary arteries in hyperhomocysteinemia: role of tumor necrosis factor-alpha, NAD(P)H oxidase, and inducible nitric oxide synthase. Arterioscler. Thromb. Vasc. Biol. 23: 418–424
16. 16. N.P. Dudman S.E. Temple X.W. Guo W. Fu M.A. Perry 1999 Homocysteine enhances neutrophil-endothelial interactions in both cultured human cells and rats in vivo Circ. Res. 84 409 416 10066675 1:CAS:528:DyaK1MXhs12lsLs%3D Dudman N.P., Temple S.E., Guo X.W., Fu W., Perry M.A. (1999) Homocysteine enhances neutrophil-endothelial interactions in both cultured human cells and rats in vivo. Circ. Res. 84: 409–416
17. 17. T. Koga K. Claycombe M. Meydani 2002 Homocysteine increases monocyte and T-cell adhesion to human aortic endothelial cells Atherosclerosis 161 365 374 11888519 10.1016/S0021-9150(01)00670-0 1:CAS:528:DC%2BD38XhvVWksbg%3D Koga T., Claycombe K., Meydani M. (2002) Homocysteine increases monocyte and T-cell adhesion to human aortic endothelial cells. Atherosclerosis 161: 365–374
18. 18. M.D. Silverman R.J. Tumuluri M. Davis G. Lopez J.T. Rosenbaum P.I. Lelkes 2002 Homocysteine upregulates vascular cell adhesion molecule-1 expression in cultured human aortic endothelial cells and enhances monocyte adhesion Arterioscler. Thromb. Vasc. Biol. 22 587 592 11950695 10.1161/01.ATV.0000014221.30108.08 1:CAS:528:DC%2BD38XjtVOru74%3D Silverman M.D., Tumuluri R.J., Davis M., Lopez G., Rosenbaum J.T., Lelkes P.I. (2002) Homocysteine upregulates vascular cell adhesion molecule-1 expression in cultured human aortic endothelial cells and enhances monocyte adhesion. Arterioscler. Thromb. Vasc. Biol. 22: 587–592
19. 19. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344: 1383–1389, 1994
20. 20. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360: 7–22, 2002
21. 21. A.M. Gotto Jr. J.A. Farmer 2001 Pleiotropic effects of statins: do they matter? Curr. Opin. Lipidol. 12 391 394 10.1097/00041433-200108000-00004 1:CAS:528:DC%2BD3MXlsFOgu7Y%3D Gotto A.M. Jr., Farmer J.A. (2001) Pleiotropic effects of statins: do they matter? Curr. Opin. Lipidol. 12: 391–394
22. 22. M. Takemoto J.K. Liao 2001 Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors Arterioscler. Thromb. Vasc. Biol. 21 1712 1719 11701455 10.1161/hq1101.098486 1:CAS:528:DC%2BD3MXosVKntLw%3D Takemoto M., Liao J.K. (2001) Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler. Thromb. Vasc. Biol. 21: 1712–1719
23. 23. C. Arnaud N.R. Veillard F. Mach 2005 Cholesterol-independent effects of statins in inflammation, immunomodulation and atherosclerosis Curr. Drug Targets Cardiovasc. Haematol. Disord. 5 127 134 15853754 10.2174/1568006043586198 1:CAS:528:DC%2BD2MXktlagsLs%3D Arnaud C., Veillard N.R., Mach F. (2005) Cholesterol-independent effects of statins in inflammation, immunomodulation and atherosclerosis. Curr. Drug Targets Cardiovasc. Haematol. Disord. 5: 127–134
24. 24. F.M. Sacks M.A. Pfeffer L.A. Moye J.L. Rouleau J.D. Rutherford T.G. Cole L. Brown J.W. Warnica J.M. Arnold C.C. Wun B.R. Davis E. Braunwald 1996 The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent events trial investigators N. Engl. J. Med. 335 1001 1009 8801446 10.1056/NEJM199610033351401 1:CAS:528:DyaK28XmsFWls7c%3D Sacks F.M., Pfeffer M.A., Moye L.A., Rouleau J.L., Rutherford J.D., Cole T.G., Brown L., Warnica J.W., Arnold J.M., Wun C.C., Davis B.R., Braunwald E. (1996) The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent events trial investigators. N. Engl. J. Med. 335: 1001–1009
25. 25. J.R. Downs M. Clearfield S. Weis E. Whitney D.R. Shapiro P.A. Beere A. Langendorfer E.A. Stein W. Kruyer A.M. Gotto Jr 1998 Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study JAMA 279 1615 1622 9613910 10.1001/jama.279.20.1615 1:STN:280:DyaK1c3ntl2qsw%3D%3D Downs J.R., Clearfield M., Weis S., Whitney E., Shapiro D.R., Beere P.A., Langendorfer A., Stein E.A., Kruyer W., Gotto A.M. Jr (1998) Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 279: 1615–1622
26. 26. S.P. Zhao L. Liu Y.C. Cheng Y.L. Li 2003 Effect of xuezhikang, a cholestin extract, on reflecting postprandial triglyceridemia after a high-fat meal in patients with coronary heart disease Atherosclerosis 168 375 380 12801622 10.1016/S0021-9150(03)00142-4 1:CAS:528:DC%2BD3sXksVOku7k%3D Zhao S.P., Liu L., Cheng Y.C., Li Y.L. (2003) Effect of xuezhikang, a cholestin extract, on reflecting postprandial triglyceridemia after a high-fat meal in patients with coronary heart disease. Atherosclerosis 168: 375–380
27. 27. Y. Aniya I.I. Ohtani T. Higa C. Miyagi H. Gibo M. Shimabukuro H. Nakanishi J. Taira 2000 Dimerumic acid as an antioxidant of the mold, Monascus anka Free Radic. Biol. Med. 28 999 1004 10802232 10.1016/S0891-5849(00)00188-X 1:CAS:528:DC%2BD3cXivVGmsrk%3D Aniya Y., Ohtani I.I., Higa T., Miyagi C., Gibo H., Shimabukuro M., Nakanishi H., Taira J. (2000) Dimerumic acid as an antioxidant of the mold, Monascus anka. Free Radic. Biol. Med. 28: 999–1004
28. 28. Y. Aniya T. Yokomakura M. Yonamine K. Shimada T. Nagamine M. Shimabukuro H. Gibo 1999 Screening of antioxidant action of various molds and protection of Monascus anka against experimentally induced liver injuries of rats Gen. Pharmacol. 32 225 231 10188624 10.1016/S0306-3623(98)00183-9 1:CAS:528:DyaK1MXhvFegsb8%3D Aniya Y., Yokomakura T., Yonamine M., Shimada K., Nagamine T., Shimabukuro M., Gibo H. (1999) Screening of antioxidant action of various molds and protection of Monascus anka against experimentally induced liver injuries of rats. Gen. Pharmacol. 32: 225–231
29. 29. J. Taira C. Miyagi Y. Aniya 2002 Dimerumic acid as an antioxidant from the mold, Monascus anka: the inhibition mechanisms against lipid peroxidation and hemeprotein-mediated oxidation Biochem. Pharmacol. 63 1019 1026 11911855 10.1016/S0006-2952(01)00923-6 1:CAS:528:DC%2BD38XitFWls7c%3D Taira J., Miyagi C., Aniya Y. (2002) Dimerumic acid as an antioxidant from the mold, Monascus anka: the inhibition mechanisms against lipid peroxidation and hemeprotein-mediated oxidation. Biochem. Pharmacol. 63: 1019–1026
30. 30. L. Liu S.P. Zhao Y.C. Cheng Y.L. Li 2003 Xuezhikang decreases serum lipoprotein(a) and C-reactive protein concentrations in patients with coronary heart disease Clin. Chem. 49 1347 1352 12881451 10.1373/49.8.1347 Liu L., Zhao S.P., Cheng Y.C., Li Y.L. (2003) Xuezhikang decreases serum lipoprotein(a) and C-reactive protein concentrations in patients with coronary heart disease. Clin. Chem. 49: 1347–1352
31. 31. S.P. Zhao L. Liu Y.C. Cheng M.H. Shishehbor M.H. Liu D.Q. Peng Y.L. Li 2004 Xuezhikang, an extract of cholestin, protects endothelial function through antiinflammatory and lipid-lowering mechanisms in patients with coronary heart disease Circulation 110 915 920 15313947 10.1161/01.CIR.0000139985.81163.CE Zhao S.P., Liu L., Cheng Y.C., Shishehbor M.H., Liu M.H., Peng D.Q., Li Y.L. (2004) Xuezhikang, an extract of cholestin, protects endothelial function through antiinflammatory and lipid-lowering mechanisms in patients with coronary heart disease. Circulation 110: 915–920
32. 32. J.J. Li S.S. Hu C.H. Fang R.T. Hui L.F. Miao Y.J. Yang R.L. Gao 2005 Effects of xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with stable angina Clin. Chim. Acta 352 217 224 15653117 10.1016/j.cccn.2004.09.026 1:CAS:528:DC%2BD2MXkvFalsA%3D%3D Li J.J., Hu S.S., Fang C.H., Hui R.T., Miao L.F., Yang Y.J., Gao R.L. (2005) Effects of xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with stable angina. Clin. Chim. Acta 352: 217–224
33. 33. C.L. Hu Y.B. Li Y.H. Tang J.B. Chen J. Liu Q.Z. Tang Q.H. Zhang C.X. Huang 2006 Effects of withdrawal of Xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with coronary artery disease Cardiovasc. Drugs Ther. 20 185 191 16775668 10.1007/s10557-006-7947-x 1:CAS:528:DC%2BD28XntFSmtLg%3D Hu C.L., Li Y.B., Tang Y.H., Chen J.B., Liu J., Tang Q.Z., Zhang Q.H., Huang C.X. (2006) Effects of withdrawal of Xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with coronary artery disease. Cardiovasc. Drugs Ther. 20: 185–191
34. 34. S.P. Zhao Z.L. Lu B.M. Du Z. Chen Y.F. Wu X.H. Yu Y.C. Zhao L. Liu H.J. Ye Z.H. Wu 2007 Xuezhikang, an extract of cholestin, reduces cardiovascular events in type 2 diabetes patients with coronary heart disease: subgroup analysis of patients with type 2 diabetes from China coronary secondary prevention study (CCSPS) J. Cardiovasc. Pharmacol. 49 81 84 17312447 10.1097/FJC.0b013e31802d3a58 1:CAS:528:DC%2BD2sXhvFSjtLY%3D Zhao S.P., Lu Z.L., Du B.M., Chen Z., Wu Y.F., Yu X.H., Zhao Y.C., Liu L., Ye H.J., Wu Z.H. (2007) Xuezhikang, an extract of cholestin, reduces cardiovascular events in type 2 diabetes patients with coronary heart disease: subgroup analysis of patients with type 2 diabetes from China coronary secondary prevention study (CCSPS). J. Cardiovasc. Pharmacol. 49: 81–84
35. 35. Y.H. Chen S.J. Lin Y.L. Chen P.L. Liu J.W. Chen 2006 Anti-inflammatory effects of different drugs/agents with antioxidant property on endothelial expression of adhesion molecules Cardiovasc. Hematol. Disord. Drug Targets 6 279 304 17378773 1:CAS:528:DC%2BD28Xht1SmsrvE Chen Y.H., Lin S.J., Chen Y.L., Liu P.L., Chen J.W. (2006) Anti-inflammatory effects of different drugs/agents with antioxidant property on endothelial expression of adhesion molecules. Cardiovasc. Hematol. Disord. Drug Targets 6: 279–304
36. 36. R. Ross 1999 Atherosclerosis–an inflammatory disease N. Engl. J. Med. 340 115 126 9887164 10.1056/NEJM199901143400207 1:STN:280:DyaK1M%2FptFSqtQ%3D%3D Ross R. (1999) Atherosclerosis–an inflammatory disease. N. Engl. J. Med. 340: 115–126
37. 37. G.M. Puddu E. Cravero G. Arnone A. Muscari P. Puddu 2005 Molecular aspects of atherogenesis: new insights and unsolved questions J. Biomed. Sci. 12 839 853 16328782 10.1007/s11373-005-9024-z 1:CAS:528:DC%2BD28XivVSjs7g%3D Puddu G.M., Cravero E., Arnone G., Muscari A., Puddu P. (2005) Molecular aspects of atherogenesis: new insights and unsolved questions. J. Biomed. Sci. 12: 839–853
38. 38. B. Yu S. Wang Y. Zhang J. Song D. Zeng 2001 Effects of Xuezhikang on the proliferation of cultured aortic smooth muscle cells of rabbits J. Chin. Med. Univ. 30 264 265 1:CAS:528:DC%2BD3MXntVWjs7w%3D Yu B., Wang S., Zhang Y., Song J., Zeng D. (2001) Effects of Xuezhikang on the proliferation of cultured aortic smooth muscle cells of rabbits. J. Chin. Med. Univ. 30: 264–265
39. 39. A.A. Welder 1992 A primary culture system of adult rat heart cells for the evaluation of cocaine toxicity Toxicology 72 175 187 1566279 10.1016/0300-483X(92)90111-Q 1:CAS:528:DyaK38XisVygtL0%3D Welder A.A. (1992) A primary culture system of adult rat heart cells for the evaluation of cocaine toxicity. Toxicology 72: 175–187
40. 40. J.W. Chen Y.H. Chen F.Y. Lin Y.L. Chen S.J. Lin 2003 Ginkgo biloba extract inhibits tumor necrosis factor-alpha-induced reactive oxygen species generation, transcription factor activation, and cell adhesion molecule expression in human aortic endothelial cells Arterioscler. Thromb. Vasc. Biol. 23 1559 1566 12893683 10.1161/01.ATV.0000089012.73180.63 1:CAS:528:DC%2BD3sXntVWrt78%3D Chen J.W., Chen Y.H., Lin F.Y., Chen Y.L., Lin S.J. (2003) Ginkgo biloba extract inhibits tumor necrosis factor-alpha-induced reactive oxygen species generation, transcription factor activation, and cell adhesion molecule expression in human aortic endothelial cells. Arterioscler. Thromb. Vasc. Biol. 23: 1559–1566
41. 41. P.L. Liu Y.L. Chen Y.H. Chen S.J. Lin Y.R. Kou 2005 Wood smoke extract induces oxidative stress-mediated caspase-independent apoptosis in human lung endothelial cells: role of AIF and EndoG Am. J. Physiol. Lung Cell. Mol. Physiol. 289 L739 749 15964899 10.1152/ajplung.00099.2005 1:CAS:528:DC%2BD2MXht1Cnt7rM Liu P.L., Chen Y.L., Chen Y.H., Lin S.J., Kou Y.R. (2005) Wood smoke extract induces oxidative stress-mediated caspase-independent apoptosis in human lung endothelial cells: role of AIF and EndoG. Am. J. Physiol. Lung Cell. Mol. Physiol. 289: L739–749
42. 42. Y.H. Chen S.J. Lin J.W. Chen H.H. Ku Y.L. Chen 2002 Magnolol attenuates VCAM-1 expression in vitro in TNF-alpha-treated human aortic endothelial cells and in vivo in the aorta of cholesterol-fed rabbits Br. J. Pharmacol. 135 37 47 11786478 10.1038/sj.bjp.0704458 1:CAS:528:DC%2BD38XovVegsg%3D%3D Chen Y.H., Lin S.J., Chen J.W., Ku H.H., Chen Y.L. (2002) Magnolol attenuates VCAM-1 expression in vitro in TNF-alpha-treated human aortic endothelial cells and in vivo in the aorta of cholesterol-fed rabbits. Br. J. Pharmacol. 135: 37–47
43. 43. K. Reyes-Gordillo J. Segovia M. Shibayama P. Vergara M.G. Moreno P. Muriel 2007 Curcumin protects against acute liver damage in the rat by inhibiting NF-kappaB, proinflammatory cytokines production and oxidative stress Biochim. Biophys. Acta 1770 989 996 17383825 1:CAS:528:DC%2BD2sXkslChu70%3D Reyes-Gordillo K., Segovia J., Shibayama M., Vergara P., Moreno M.G., Muriel P. (2007) Curcumin protects against acute liver damage in the rat by inhibiting NF-kappaB, proinflammatory cytokines production and oxidative stress. Biochim. Biophys. Acta 1770: 989–996
44. 44. C.H. Tsai R.C. Chang J.F. Chiou T.Z. Liu 2003 Improved superoxide-generating system suitable for the assessment of the superoxide-scavenging ability of aqueous extracts of food constituents using ultraweak chemiluminescence J. Agric. Food Chem. 51 58 62 12502385 10.1021/jf020799t 1:CAS:528:DC%2BD38XptFCgsbo%3D Tsai C.H., Chang R.C., Chiou J.F., Liu T.Z. (2003) Improved superoxide-generating system suitable for the assessment of the superoxide-scavenging ability of aqueous extracts of food constituents using ultraweak chemiluminescence. J. Agric. Food Chem. 51: 58–62
45. 45. C.H. Tsai A. Stern J.F. Chiou C.L. Chern T.Z. Liu 2001 Rapid and specific detection of hydroxyl radical using an ultraweak chemiluminescence analyzer and a low-level chemiluminescence emitter: application to hydroxyl radical-scavenging ability of aqueous extracts of Food constituents J. Agric. Food Chem. 49 2137 2141 11368567 10.1021/jf001071k 1:CAS:528:DC%2BD3MXisl2ktbg%3D Tsai C.H., Stern A., Chiou J.F., Chern C.L., Liu T.Z. (2001) Rapid and specific detection of hydroxyl radical using an ultraweak chemiluminescence analyzer and a low-level chemiluminescence emitter: application to hydroxyl radical-scavenging ability of aqueous extracts of Food constituents. J. Agric. Food Chem. 49: 2137–2141
46. 46. C.W. Chen J.F. Chiou C.H. Tsai C.W. Shu M.H. Lin T.Z. Liu L.Y. Tsai 2006 Development of probe-based ultraweak chemiluminescence technique for the detection of a panel of four oxygen-derived free radicals and their applications in the assessment of radical-scavenging abilities of extracts and purified compounds from food and herbal preparations J. Agric. Food Chem. 54 9297 9302 17147410 10.1021/jf061779k 1:CAS:528:DC%2BD28Xht1WksLzI Chen C.W., Chiou J.F., Tsai C.H., Shu C.W., Lin M.H., Liu T.Z., Tsai L.Y. (2006) Development of probe-based ultraweak chemiluminescence technique for the detection of a panel of four oxygen-derived free radicals and their applications in the assessment of radical-scavenging abilities of extracts and purified compounds from food and herbal preparations. J. Agric. Food Chem. 54: 9297–9302
47. 47. N.J. Miller C. Rice-Evans M.J. Davies V. Gopinathan A. Milner 1993 A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates Clin. Sci. (Lond.) 84 407 412 1:STN:280:ByyB2crksFI%3D Miller N.J., Rice-Evans C., Davies M.J., Gopinathan V., Milner A. (1993) A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin. Sci. (Lond.) 84: 407–412
48. 48. K.K. Au-Yeung C.W. Woo F.L. Sung J.C. Yip Y.L. Siow O. Karmin 2004 Hyperhomocysteinemia activates nuclear factor-kappaB in endothelial cells via oxidative stress Circ. Res. 94 28 36 14630727 10.1161/01.RES.0000108264.67601.2C 1:CAS:528:DC%2BD2cXhtFSk Au-Yeung K.K., Woo C.W., Sung F.L., Yip J.C., Siow Y.L., Karmin O. (2004) Hyperhomocysteinemia activates nuclear factor-kappaB in endothelial cells via oxidative stress. Circ. Res. 94: 28–36
49. 49. J.M. Munro 1993 Endothelial-leukocyte adhesive interactions in inflammatory diseases Eur. Heart J. 14 Suppl K 72 77 7510638 Munro J.M. (1993) Endothelial-leukocyte adhesive interactions in inflammatory diseases. Eur. Heart J. 14 Suppl K: 72–77
50. 50. D.T. Price J. Loscalzo 1999 Cellular adhesion molecules and atherogenesis Am. J. Med. 107 85 97 10403357 10.1016/S0002-9343(99)00153-9 1:CAS:528:DyaK1MXkslKiurc%3D Price D.T., Loscalzo J. (1999) Cellular adhesion molecules and atherogenesis. Am. J. Med. 107: 85–97
51. 51. M.A. Hofmann E. Lalla Y. Lu M.R. Gleason B.M. Wolf N. Tanji L.J. Ferran Jr. B. Kohl V. Rao W. Kisiel D.M. Stern A.M. Schmidt 2001 Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model J. Clin. Invest. 107 675 683 11254667 10.1172/JCI10588 1:CAS:528:DC%2BD3MXitVGns70%3D Hofmann M.A., Lalla E., Lu Y., Gleason M.R., Wolf B.M., Tanji N., Ferran L.J. Jr., Kohl B., Rao V., Kisiel W., Stern D.M., Schmidt A.M. (2001) Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J. Clin. Invest. 107: 675–683
52. 52. M.J. Lenardo D. Baltimore 1989 NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control Cell 58 227 229 2665943 10.1016/0092-8674(89)90833-7 1:CAS:528:DyaL1MXltFehtLw%3D Lenardo M.J., Baltimore D. (1989) NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 58: 227–229
53. 53. S. Ghosh D. Baltimore 1990 Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B Nature 344 678 682 2157987 10.1038/344678a0 1:CAS:528:DyaK3cXitFamu7o%3D Ghosh S., Baltimore D. (1990) Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B. Nature 344: 678–682
54. 54. R. Schreck B. Meier D.N. Mannel W. Droge P.A. Baeuerle 1992 Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells J. Exp. Med. 175 1181 1194 1314883 10.1084/jem.175.5.1181 1:CAS:528:DyaK38XhvVyjsb8%3D Schreck R., Meier B., Mannel D.N., Droge W., Baeuerle P.A. (1992) Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J. Exp. Med. 175: 1181–1194
55. 55. G. Wang C.W. Woo F.L. Sung Y.L. Siow O. Karmin 2002 Increased monocyte adhesion to aortic endothelium in rats with hyperhomocysteinemia: role of chemokine and adhesion molecules Arterioscler. Thromb. Vasc. Biol. 22 1777 1783 12426204 10.1161/01.ATV.0000035404.18281.37 1:CAS:528:DC%2BD38Xot1OitLo%3D Wang G., Woo C.W., Sung F.L., Siow Y.L., O.K. (2002) Increased monocyte adhesion to aortic endothelium in rats with hyperhomocysteinemia: role of chemokine and adhesion molecules. Arterioscler. Thromb. Vasc. Biol. 22: 1777–1783
56. 56. N. Weiss 2005 Mechanisms of increased vascular oxidant stress in hyperhomocys-teinemia and its impact on endothelial function Curr. Drug Metab. 6 27 36 15720205 10.2174/1389200052997357 1:CAS:528:DC%2BD2MXhsVCqtLw%3D Weiss N. (2005) Mechanisms of increased vascular oxidant stress in hyperhomocys-teinemia and its impact on endothelial function. Curr. Drug Metab. 6: 27–36
57. 57. F. Franzoni A. Quinones-Galvan F. Regoli E. Ferrannini F. Galetta 2003 A comparative study of the in vitro antioxidant activity of statins Int. J. Cardiol. 90 317 321 12957768 10.1016/S0167-5273(02)00577-6 Franzoni F., Quinones-Galvan A., Regoli F., Ferrannini E., Galetta F. (2003) A comparative study of the in vitro antioxidant activity of statins. Int. J. Cardiol. 90: 317–321
58. 58. J. Haendeler J. Hoffmann A.M. Zeiher S. Dimmeler 2004 Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins Circulation 110 856 861 15289372 10.1161/01.CIR.0000138743.09012.93 1:CAS:528:DC%2BD2cXmtlOqtL8%3D Haendeler J., Hoffmann J., Zeiher A.M., Dimmeler S. (2004) Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins. Circulation 110: 856–861
59. 59. H. Jung C. Kim K. Kim C.S. Shin 2003 Color characteristics of monascus pigments derived by fermentation with various amino acids J. Agric. Food Chem. 51 1302 1306 12590473 10.1021/jf0209387 1:CAS:528:DC%2BD3sXosVWntw%3D%3D Jung H., Kim C., Kim K., Shin C.S. (2003) Color characteristics of monascus pigments derived by fermentation with various amino acids. J. Agric. Food Chem. 51: 1302–1306